Wednesday, August 26, 2020

9:00 am – 10:00 am

GS101 – Skin of Color

Dermatology providers are caring for more patients with skin of color than ever before. The purpose of this lecture is to discuss some of the unique features of skin of color and how these characteristics affect disease presentation and management.

Learning Objectives:
Identify cutaneous pigmentations disorders commonly occurring in ethnic individuals.
Explain differences in manifestatios and psychosocial impact imposed by skin disorders in ethnic populations.
Identify the pharmocodynamics, indications and possible side effects for medications in the treatment of pigmentation disorders unique to ethnic populations of color.

Virtual Room V100

Ginette Okoye, MD

10:00 am – 10:15 am

Exhibits/Break

10:30 am – 11:30 am

CS111 – Autoimmune Blistering Disorders-Bullous Pemphigoid and Pemphigus Vulgaris

To provide an overview of autoimmune blistering disorders, with a specific focus on bullous pemphigoid and pemphigus vulgaris, including appropriate evaluation and options for therapy.

Learning Objectives:
Explain and differentiated the pathophysiology of bullous pemphigoid and pemphigus vulgaris.
Differentiate clinical signs of bullous pemphigoid and pemphigus vulgaris.
Discuss and compare the pharmcological actions of common dermatologic medications used in the treatment of bullous pemphigoid and pemphigus vulgaris.

 

Virtual Room V100

Sylvia Brice, MD

10:30 am – 11:30 am

CS112 – Gut Microbiome and the Gut-Skin Axis

The lecture will explore the mechanisms by which the gut microbiome connects to the rest of the body and the evidence for how gut health and the gut microbiome connects to the skin. The biochemical basis for the gut-skin axis will be discussed along with the evidence for the impact of antibiotics and the use of probiotics within dermatology.

Learning Objectives:
Explain the concept of gut microbiome health.
Describe the pathogenesis of selected dermatological skin diseases that are correlated to the gut microbiome.
Compare holistic treatment measures with pharmcological options including the classification of medications, dosages, mechanism of action, and potential side effects of each.

 

Virtual Room V200

Raja Sivamani, MD

11:30 am – 12:00 pm

Exhibits/Break

12:00 pm – 1:00 pm

GS121 – High Risk Systemic Medications Used in Dermatology

This presentation will focus on systemic medications commonly used in dermatology. It will provide an overview of drug induced toxicity and recommendations for pre-treatment assessment and monitoring for drug induced side effects. Identify selected dermatologic conditions that would require treatment with high risk systemic medication.

Learning Objectives:
Describe the pharmcodynamics of selected high-risk dematologic medications that can result in drug induced toxicity.
Identify and interpret specific diagnostic testing for monitoring patients on high risk dermatologic systemic medications.

Virtual Room V100

Sylvia Brice, MD

1:00 pm – 1:30 pm

Exhibits/Break

1:30 pm – 2:30 pm

CS131 – Psoriatic Disease in 2020: Essential Updates

This session will provide the essential psoriasis management updates that every dermatology nurse and advanced practice nurse needs to know. This includes an overview of the key clinical features of the various manifestations of psoriasis, newly identified comorbidities associated with psoriatic disease, and new treatment targets. The session will provide an interactive, case-based presentation that will ensure that you are up-to-date on your psoriatic disease knowledge.

Learning Objectives:
Explain the pathophysiology and clinical manifestation of psoriasis vulgaris.
Identify 5 essential treatment targets for the treatment of psoriasis.
Describe pharmacokinetics, medication classifications, indications, actions and dosages of at least 3 medications used in the treatment of psoriasis.

Virtual Room V100

Lakshi Aldredge, MSN, ANP-BC, DCNP

1:30 pm – 2:30 pm

CS132 – Dermatologic Emergencies

Increase your awareness of dermatologic presentations that require an immediate response; Review three ‘red flag’ cutaneous presentations: Erythematous eruption,Erythrodermic eruption, Bullous eruption; Help differentiate between signs and symptoms of serious skin disorders and benign findings (‘red flag’ mimics).

Learning Objectives:
Describe the pathophysiology of at least three (3) dermatologic emergencies.
Explain crucial assessment of signs and symptoms of identified dermatologic emergencies.
Discuss the urgent clinical management and interventions for each emergency cutaneous manifestation.

Virtual Room V200

Sabrina Newman, MD